Forte Biosciences, Inc. ( FBRX) - Stock Earnings
FBRX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
FBRX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -24.8 million USD | — USD |
| 2026Q1 | -22.1 million USD | — USD |
| 2026Q2 | -23.3 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
FBRX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -31.5 million USD | — USD |
| 2024 | -35.5 million USD | — USD |
| 2025 | -69.4 million USD | — USD |
| 2026 Est. | — | — |
FBRX
Price: $76.83
52 week price:
Earnings Per Share: -4.57 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 50864
Market Capitalization: 1.6 billion